Healthcare & Life Sciences
Phoenix Molecular Designs
About
Phoenix Molecular Designs is a clinical-stage biotechnology company developing first-in-class RSK kinase inhibitors as targeted therapies for cancer.
Explore Phoenix Molecular Designs's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.